Insights and Hopes in Umbilical Cord Blood Stem Cell Transplantations

Overview

Journal J Biomed Biotechnol

Specialty Biology

Date 2012 Dec 22

PMID 23258957

Citations 10

Authors

Somayeh Shahrokhi

Farid Menaa

Kamran Alimoghaddam

Colin McGuckin

Massoumeh Ebtekar

Affiliations

Soon will be listed here.

Abstract

Over 20.000 umblical cord blood transplantations (UCBT) have been carried out around the world. Indeed, UCBT represents an attractive source of donor hematopoietic stem cells (HSCs) and, offer interesting features (e.g., lower graft-versus-host disease) compared to bone marrow transplantation (BMT). Thereby, UCBT often represents the unique curative option against several blood diseases. Recent advances in the field of UCBT, consisted to develop strategies to expand umbilical stem cells and shorter the timing of their engraftment, subsequently enhancing their availability for enhanced efficacy of transplantation into indicated patients with malignant diseases (e.g., leukemia) or non-malignant diseases (e.g., thalassemia major). Several studies showed that the expansion and homing of UCBSCs depends on specific biological factors and cell types (e.g., cytokines, neuropeptides, co-culture with stromal cells). In this review, we extensively present the advantages and disadvantages of current hematopoietic stem cell transplantations (HSCTs), compared to UBCT. We further describe the importance of cord blood content and obstetric factors on cord blood selection, and report the recent approaches that can be undertook to improve cord blood stem cell expansion as well as engraftment. Eventually, we provide two majors examples underlining the importance of UCBT as a potential cure for blood diseases.

Citing Articles

Expansion of human hematopoietic stem cells by inhibiting translation.

Li C, Shin H, Bhavanasi D, Liu M, Yu X, Peslak S bioRxiv. 2023; .

PMID: 38077058 PMC: 10705409. DOI: 10.1101/2023.11.28.568925.

hUMSC vs. hUMSC-Exosome: Which One Is Better for Epilepsy?.

Hastuti S, Idroes R, Imran I, Ramli Y, Abas A, Tallei T Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297359 PMC: 9610004. DOI: 10.3390/ph15101247.

Photobiomodulation: An Effective Approach to Enhance Proliferation and Differentiation of Adipose-Derived Stem Cells into Osteoblasts.

Da Silva D, Crous A, Abrahamse H Stem Cells Int. 2021; 2021:8843179.

PMID: 33833810 PMC: 8012132. DOI: 10.1155/2021/8843179.

Epidemiology and treatment of beta thalassemia major in China.

Xu X, Wu X Pediatr Investig. 2020; 4(1):43-47.

PMID: 32851341 PMC: 7331292. DOI: 10.1002/ped4.12154.

Impact and Challenges of Mesenchymal Stem Cells in Medicine: An Overview of the Current Knowledge.

Menaa F, Shahrokhi S, Shastri V Stem Cells Int. 2019; 2018:5023925.

PMID: 30662468 PMC: 6312597. DOI: 10.1155/2018/5023925.

References

Rocha V, Broxmeyer H . New approaches for improving engraftment after cord blood transplantation. Biol Blood Marrow Transplant. 2009; 16(1 Suppl):S126-32. DOI: 10.1016/j.bbmt.2009.11.001. View

Barker J, Davies S, DeFor T, Ramsay N, Weisdorf D, Wagner J . Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 2001; 97(10):2957-61. DOI: 10.1182/blood.v97.10.2957. View

McGuckin C, Basford C, Hanger K, Habibollah S, Forraz N . Cord blood revelations: the importance of being a first born girl, big, on time and to a young mother!. Early Hum Dev. 2007; 83(12):733-41. DOI: 10.1016/j.earlhumdev.2007.09.001. View

Prasad V, Kurtzberg J . Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant. 2009; 44(10):643-51. DOI: 10.1038/bmt.2009.290. View

Willasch A, Hoelle W, Kreyenberg H, Niethammer D, Handgretinger R, Lang P . Outcome of allogeneic stem cell transplantation in children with non-malignant diseases. Haematologica. 2006; 91(6):788-94. View

Li J, Barreda D, Zhang Y, Boshra H, Gelman A, LaPatra S . B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities. Nat Immunol. 2006; 7(10):1116-24. DOI: 10.1038/ni1389. View

Ballen K, Spitzer T, Yeap B, McAfee S, Dey B, Attar E . Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007; 13(1):82-9. PMC: 2947324. DOI: 10.1016/j.bbmt.2006.08.041. View

Sanz G, Saavedra S, Jimenez C, Senent L, Cervera J, Planelles D . Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution. Bone Marrow Transplant. 2001; 27(7):693-701. DOI: 10.1038/sj.bmt.1702878. View

Broxmeyer H . Umbilical cord transplantation: epilogue. Semin Hematol. 2010; 47(1):97-103. PMC: 3312374. DOI: 10.1053/j.seminhematol.2009.10.002. View

10.

Adkins B . T-cell function in newborn mice and humans. Immunol Today. 1999; 20(7):330-5. DOI: 10.1016/s0167-5699(99)01473-5. View

11.

McKenna D, Sheth J . Umbilical cord blood: current status & promise for the future. Indian J Med Res. 2011; 134:261-9. PMC: 3193706. View

12.

Broxmeyer H, Gluckman E, Auerbach A, Douglas G, Friedman H, Cooper S . Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning. 1990; 8 Suppl 1:76-89; discussion 89-91. DOI: 10.1002/stem.5530080708. View

13.

Liao Y, Geyer M, Yang A, Cairo M . Cord blood transplantation and stem cell regenerative potential. Exp Hematol. 2011; 39(4):393-412. DOI: 10.1016/j.exphem.2011.01.002. View

14.

Gutman J, Riddell S, McGoldrick S, Delaney C . Double unit cord blood transplantation: Who wins-and why do we care?. Chimerism. 2011; 1(1):21-2. PMC: 3035116. DOI: 10.4161/chim.1.1.12141. View

15.

Jaing T, Yang C, Hung I, Chen S, Sun C, Chow R . Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant. 2007; 40(4):307-11. DOI: 10.1038/sj.bmt.1705737. View

16.

Roncarolo M, Bigler M, Ciuti E, Martino S, Tovo P . Immune responses by cord blood cells. Blood Cells. 1994; 20(2-3):573-85; discussion 585-6. View

17.

Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M . Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning.... Blood. 2006; 109(3):1322-30. DOI: 10.1182/blood-2006-04-020172. View

18.

Mancinelli F, Tamburini A, Spagnoli A, Malerba C, Suppo G, Lasorella R . Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood units. Transplant Proc. 2006; 38(4):1174-6. DOI: 10.1016/j.transproceed.2006.03.052. View

19.

Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S . Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2002; 101(6):2137-43. DOI: 10.1182/blood-2002-07-2090. View

20.

McGuckin C, Forraz N, Baradez M, Navran S, Zhao J, Urban R . Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 2005; 38(4):245-55. PMC: 6496335. DOI: 10.1111/j.1365-2184.2005.00346.x. View